Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard L Berg

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Pediatric Obesity|July 24, 2020
Bardet-Biedl syndrome: Weight patterns and genetics in a rare obesity syndromeJeremy Pomeroy, Anthony D Krentz, Jesse G Richardson, et al.
Basic & Clinical Pharmacology & Toxicology|October 7, 2008
Characterization of low-density lipoprotein cholesterol-lowering efficacy for atorvastatin in a population-based DNA biorepositoryRussell A Wilke, Richard L Berg, James G Linneman, et al.
Pharmacogenetics|July 31, 2004
Relative impact of covariates in prescribing warfarin according to CYP2C9 genotypeMichael A Hillman, Russell A Wilke, Michael D Caldwell, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 17, 2006
Acute health events in adult patients with genetic disorders: the Marshfield Epidemiologic Study AreaPhilip F Giampietro, Robert T Greenlee, Elizabeth McPherson, et al.
Clinical Medicine & Research|June 6, 2014
Reinitiating warfarin: relationships between dose and selected patient, clinical and hospital measuresLucas G Leonhard, Richard L Berg, James K Burmester, et al.
Breast Cancer Research and Treatment|April 6, 2012
High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot studyAdedayo A Onitilo, Jessica M Engel, Rachel V Stankowski, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|February 5, 2010
Risk factors for volleyball-related shoulder pain and dysfunctionJonathan C Reeser, Elizabeth A Joy, Christina A Porucznik, et al.
Clinical Medicine & Research|November 24, 2005
Impact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapyRussell A Wilke, Richard L Berg, Humberto J Vidaillet, et al.
Clinical Medicine & Research|April 26, 2007
Use of an electronic medical record for the identification of research subjects with diabetes mellitusRussell A Wilke, Richard L Berg, Peggy Peissig, et al.
BMC Medical Informatics and Decision Making|June 3, 2014
A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical recordAdedayo A Onitilo, Rachel V Stankowski, Richard L Berg, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Pediatric Obesity|July 24, 2020
Bardet-Biedl syndrome: Weight patterns and genetics in a rare obesity syndromeJeremy Pomeroy, Anthony D Krentz, Jesse G Richardson, et al.
Basic & Clinical Pharmacology & Toxicology|October 7, 2008
Characterization of low-density lipoprotein cholesterol-lowering efficacy for atorvastatin in a population-based DNA biorepositoryRussell A Wilke, Richard L Berg, James G Linneman, et al.
Pharmacogenetics|July 31, 2004
Relative impact of covariates in prescribing warfarin according to CYP2C9 genotypeMichael A Hillman, Russell A Wilke, Michael D Caldwell, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 17, 2006
Acute health events in adult patients with genetic disorders: the Marshfield Epidemiologic Study AreaPhilip F Giampietro, Robert T Greenlee, Elizabeth McPherson, et al.
Clinical Medicine & Research|June 6, 2014
Reinitiating warfarin: relationships between dose and selected patient, clinical and hospital measuresLucas G Leonhard, Richard L Berg, James K Burmester, et al.
Breast Cancer Research and Treatment|April 6, 2012
High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot studyAdedayo A Onitilo, Jessica M Engel, Rachel V Stankowski, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|February 5, 2010
Risk factors for volleyball-related shoulder pain and dysfunctionJonathan C Reeser, Elizabeth A Joy, Christina A Porucznik, et al.
Clinical Medicine & Research|November 24, 2005
Impact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapyRussell A Wilke, Richard L Berg, Humberto J Vidaillet, et al.
Clinical Medicine & Research|April 26, 2007
Use of an electronic medical record for the identification of research subjects with diabetes mellitusRussell A Wilke, Richard L Berg, Peggy Peissig, et al.
BMC Medical Informatics and Decision Making|June 3, 2014
A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical recordAdedayo A Onitilo, Rachel V Stankowski, Richard L Berg, et al.
Pageof 11